Open AccessA Preliminary Randomized Controlled Trial of Different Treatment Regimens for Melancholic Depression
Author(s) -
Yun Wang,
Xiaohua Liu,
Daihui Peng,
Yan Wu,
Yun-Ai Su,
Jia Xu,
Xiancang Ma,
Yang Li,
Jianfei Shi,
Xiaojing Cheng,
Rong Han,
Yiru Fang
Publication year - 2021
Publication title -
neuropsychiatric disease and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 67
eISSN - 1178-2021
pISSN - 1176-6328
DOI - 10.2147/ndt.s303938
Subject(s) - fluoxetine , bupropion , medicine , randomized controlled trial , clinical endpoint , depression (economics) , hamilton rating scale for depression , major depressive disorder , psychiatry , adverse effect , anesthesia , amygdala , serotonin , smoking cessation , receptor , pathology , economics , macroeconomics
Fluoxetine, bupropion, cognitive behavioral therapy (CBT), and physical therapies (modified electroconvulsive treatment or repetitive transcranial magnetic stimulation) can be used to manage melancholic depression.